Eli Lilly Reports Positive Late-Stage Results for Eczema Drug Ebglyss
Eli Lilly reported positive late-stage clinical results for its eczema treatment Ebglyss. The results are for a difficult-to-treat form of atopic dermatitis affecting the hands and feet, potentially expanding the drug's commercial opportunity.